Chemotherapy for Esophageal Cancer

Esophageal cancer occurs when malignant cells form in the esophagus, a muscular tube that connects the throat to the stomach to facilitate digestion. Usually, the tumor arises in the inner lining of the esophagus and spreads outward through the various layers of the esophageal wall. The two main types of esophageal cancer are adenocarcinoma, which affects the lower part of the esophagus, and squamous cell carcinoma, which occurs in the upper or middle sections.

The exact cause of esophageal cancer is not always known, but certain factors may increase the risk. These include chronic acid reflux or gastroesophageal reflux disease (GERD), tobacco use, heavy consumption of alcoholic beverages, obesity and a history of Barrett’s esophagus. Common symptoms include difficulty swallowing, unintentional weight loss, chest pain and persistent indigestion.

"Everybody is on the same page at Moffitt. It doesn't matter if you're with the nurses, the doctors — even billing. It's your best chance at beating cancer."

-Rick, Esophageal Cancer Survivor

Request an Appointment

Esophageal cancer is often diagnosed after age 50, although it can occur at any age. The diagnostic process may include a physical examination, imaging studies, endoscopy and tissue biopsy to confirm the presence and stage of the cancer.

Esophageal cancer treatment often involves a combination of therapies, such as surgery, chemotherapy, radiation therapy and, in some cases, targeted therapy or immunotherapy. The specific approach is fine-tuned based on several unique factors, including the location and stage of the tumor and the patient’s overall health.

When is chemotherapy used for esophageal cancer?

Chemotherapy can be used for esophageal cancer at various stages. The timing can differ based on the goals of treatment. For instance, a customized regimen of chemo drugs may be administered:

• Before surgery – To shrink the tumor and improve the surgical outcome
• After surgery – To target any remaining microscopic cancer cells and help reduce the risk of recurrence
• Alongside radiation therapy (chemoradiation) – To heighten the effectiveness of treatment
• As a primary treatment for advanced or metastatic esophageal cancer – To slow the progression of the tumor and relieve the related symptoms
• As an alternative to surgery – To provide a treatment option for a patient who is not a surgical candidate

What does chemotherapy for esophageal cancer involve?

Chemotherapy for esophageal cancer involves the use of strong cancer-fighting drugs that enter the bloodstream and circulate throughout the body to reach widespread cancer cells. These potent medications are designed to destroy actively dividing cells or interfere with their ability to grow and multiply. Because cancer cells divide more rapidly than most healthy cells, they are particularly vulnerable to the effects of chemo.

The most commonly used chemotherapy drugs for esophageal cancer are cisplatin, carboplatin, 5-fluorouracil (5-FU), paclitaxel and docetaxel. These drugs may be used alone or in combination to enhance their effectiveness. For example, a frequently prescribed regimen includes cisplatin and 5-FU, sometimes combined with radiation therapy.

In most cases, chemotherapy for esophageal cancer is delivered intravenously, although some regimens may also include oral medications. The frequency, duration and specific combination of drugs can vary depending on the stage of the tumor, the overall health of the patient and the goals of treatment, such as shrinking a tumor before surgery or controlling the symptoms of advanced cancer.

Chemotherapy is usually administered in cycles, with each cycle consisting of a period of drug infusion followed by a period of rest. This phased treatment approach allows the body time to recover from any side effects and rebuild healthy cells that may have been damaged by the chemo drugs, such as those found in the bone marrow and digestive tract.

What happens during chemotherapy for esophageal cancer?

Chemotherapy for esophageal cancer is usually infused into a vein, often in an outpatient infusion center. Intravenous chemotherapy may be delivered through a:

• Cannula – A short, flexible tube is placed in a vein in the back of the hand or lower arm.
• Central line – A long, thin tube is inserted into a vein in the chest.
• Peripherally inserted central venous catheter (PICC) line – A long, thin tube is placed in a vein in the arm and guided to the larger central veins near the heart.
• Implantable port (portacath) – A soft, thin, hollow tube is inserted into a vein, tunneled under the skin and connected to a port placed under the skin of the chest or arm.

Once the cannula, line or port is in place, the chemotherapy drugs may be delivered via injection, drip or pump. The infusion process can take anywhere from a few minutes to several hours, depending on the specifics of the treatment plan.

What are the possible side effects of chemotherapy for esophageal cancer?

Chemotherapy for esophageal cancer may cause side effects, mainly because these powerful drugs indiscriminately target all rapidly dividing cells throughout the body. Sometimes, in addition to cancer cells, chemo affects healthy cells that naturally divide rapidly, such as those found in the bone marrow, hair follicles, digestive tract and immune system. This can cause a variety of side effects depending on the type of drugs used, the dosage, the cells affected and the patient’s overall health.

Common side effects of chemotherapy include:

• Decreased appetite
• Diarrhea
• Fatigue
• Hair thinning or hair loss
• Mouth sores
• Nausea or vomiting

Most of these side effects are temporary and can be managed with supportive medications and lifestyle adjustments.

Florida's Top Choice for Cancer Care

Moffitt is Florida's top cancer hospital by expert opinion in America's Best Cancer Hospitals by U.S. News & World Report.

Schedule an Appointment

What are the risks and possible complications of chemotherapy for esophageal cancer?

Chemotherapy can be an effective treatment for esophageal cancer. However, it has certain risks and possible complications, mainly due to its potential impact on healthy cells.

One of the most significant risks of chemotherapy is bone marrow suppression, which can cause low blood cell counts. This may result in:

• Anemia due to low red blood cells
• Easy bleeding and bruising due to low platelets
• Increased risk of infection due to low white blood cells

During chemotherapy for esophageal cancer, the patient will typically undergo frequent blood testing to monitor their blood cell levels. In some cases, blood transfusions or medications may be needed to support blood cell production.

Another possible complication of chemotherapy for esophageal cancer is nerve cell damage, which may cause peripheral neuropathy. Common symptoms include pain, numbness and tingling sensations in the hands and feet. In some cases, long-term chemotherapy can also impact kidney function and heart health.

To manage these risks and help the patient better tolerate chemotherapy, the physician will continually refine the treatment plan, prescribe supportive medications and suggest symptom management strategies as needed. While chemo side effects can be disruptive, most are temporary and manageable, and chemotherapy remains a key tool in controlling esophageal cancer and improving the patient’s outcome and quality of life.

What to expect during recovery from chemotherapy for esophageal cancer

After completing chemotherapy for esophageal cancer, the patient will enter a recovery phase that involves close monitoring for side effects and potential complications. During this time, periodic blood tests may be performed to assess blood cell counts, kidney function and how well the cancer is responding to treatment. Based on the findings, the physician may adjust the chemotherapy regimen or recommend additional supportive measures as needed.

The recovery timeline can vary depending on the specific drugs used, the intensity of treatment and the patient’s overall health. Most individuals regain their strength slowly, and some side effects may persist beyond the final chemotherapy session. Managing symptoms such as fatigue, nausea, appetite changes and weakness is often an important part of recovery. Because chemo can suppress the immune system, the patient will be advised to take extra precautions against infection, such as practicing meticulous hand hygiene, avoiding close contact with anyone who is sick and following medical recommendations regarding vaccinations and immune-boosting medications.

In some cases, further treatment may be needed to support recovery or prevent cancer recurrence. This might include medications to manage lingering side effects, blood transfusions to correct anemia or targeted therapies tailored to the patient’s cancer profile. Recovery from chemotherapy is a gradual process, and long-term well-being often depends on continued follow-up care, healthy lifestyle changes and a strong partnership with the healthcare team.

How effective is chemotherapy for esophageal cancer?

Chemotherapy for esophageal cancer can be effective, particularly in shrinking the tumor, increasing the likelihood of surgical success and reducing the risk of recurrence. Response rates vary, but some patients experience significant tumor shrinkage and improved function.

While chemotherapy is not typically curative for advanced or metastatic esophageal cancer, it can slow the progression of the tumor, provide meaningful symptom relief and enhance the patient’s quality of life. In general, the best outcomes are usually seen when chemo is part of a multimodal treatment plan.

Benefit from world-class care at Moffitt Cancer Center

If you have questions about chemotherapy for esophageal cancer, you can request an appointment with a specialist in the Gastrointestinal Oncology Program at Moffitt by calling 1-888-663-3488 or submitting a new patient registration form online. Chemotherapy for esophageal cancer is available at all Moffitt locations, and we do not require referrals.